Come True Biomedical Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 5.877 million compared to TWD 10.658 million a year ago. Operating loss was TWD 2.619 million compared to TWD 3.747 million a year ago. Net loss was TWD 1.854 million compared to TWD 3.749 million a year ago. Basic loss per share was TWD 0.06 compared to TWD 0.12 a year ago. For the half year, total revenue was TWD 15.437 million compared to TWD 21.479 million a year ago. Operating loss was TWD 6.158 million compared to TWD 6.843 million a year ago. Net loss was TWD 4.013 million compared to TWD 5.740 million a year ago. Basic loss per share was TWD 0.13 compared to TWD 0.18 a year ago.